Question 1

What does ICH Q7 compliance mean for a botanical API manufacturer?

Accepted Answer

ICH Q7 is the international GMP guideline specifically for Active Pharmaceutical Ingredient (API) manufacturers. For botanical APIs, it means the entire production process — from raw material sourcing and extraction through purification, drying, milling, and packaging — is conducted under documented, validated, and auditable conditions. This includes batch manufacturing records, validated analytical methods, personnel training programs, environmental monitoring in ISO Class 7 cleanrooms, and full chain-of-custody traceability from agricultural raw material to final crystal.

Question 2

What is PIC/S certification and why does it matter for pharmaceutical API buyers?

Accepted Answer

PIC/S (Pharmaceutical Inspection Co-operation Scheme) is a cooperative arrangement between pharmaceutical regulatory authorities that harmonizes GMP standards globally. A PIC/S-certified facility has been inspected by a member regulatory authority and found to meet the standards in PIC/S Guide PE009. For API buyers in the EU (EDQM), UK (MHRA), and Australia (TGA), PIC/S certification is directly recognized, simplifying supplier qualification audits and Drug Master File submissions. It typically takes 18–24 months to achieve PIC/S certification from greenfield.

Question 3

How do I reference Phytrax's Drug Master File (DMF) in my regulatory submission?

Accepted Answer

Qualified pharmaceutical buyers can request a DMF Reference Letter from Phytrax Lifesciences after signing a mutual NDA. The letter authorizes the regulatory authority to access the confidential sections of our Type II DMF (US FDA) or ASMF (EU). Required documentation includes your company's drug product IND/NDA number, regulatory contact details, and a signed supply agreement. Our business development team provides a full technical package including a 5-kg sample, COA, method transfer protocol, and stability data within the onboarding process.

Question 4

What is the minimum order quantity (MOQ) for bulk botanical API?

Accepted Answer

Minimum order quantities vary by product: Galantamine HBr USP (5 kg), Mitragynine 95% Isolate (10 kg), Nuciferine 98% (10 kg), Hyoscyamine Sulfate (5 kg, made-to-order with 50% deposit). GMP analytical reference standard samples (1–5 g) are available separately for method development and supplier qualification purposes. All orders below 25 kg are packed in double-sealed HDPE containers rather than full drums.

Question 5

What analytical testing is included with every batch of API?

Accepted Answer

Every released batch includes a full Certificate of Analysis (COA) covering: appearance and physical description; identity by infrared spectroscopy (IR) and/or TLC; assay (purity) by validated HPLC method; related substances and impurity profile by HPLC; residual solvents by GC headspace (ICH Q3C Class 2 limits); heavy metals by ICP-OES (As, Cd, Hg, Pb); microbial limits — total aerobic microbial count (TAMC), total yeast and mold count (TYMC), E. coli absent; and moisture content by Karl Fischer titration. Stability data under ICH Q1A conditions is available on request.

Question 6

What is the typical lead time for a bulk botanical API order?

Accepted Answer

Standard lead times from order confirmation: Mitragynine 95% (3 weeks ex-works), Nuciferine 98% (2 weeks ex-works), Galantamine HBr USP (5 weeks ex-works), Hyoscyamine Sulfate MTO (8 weeks ex-works). Additional 1–2 weeks should be budgeted for export documentation, phytosanitary certificates, and freight forwarding depending on destination. Rush production scheduling (within 2 weeks) is available for established customers with pre-signed supply agreements.

Question 7

Is Galantamine HBr sourced from Crinum viviparum or Galanthus?

Accepted Answer

Phytrax sources galantamine from Crinum viviparum, an Amaryllidaceae species cultivated on 200 rai (32 hectares) of dedicated contract farmland in Chachoengsao Province, Thailand. C. viviparum is a documented galantamine-containing species in peer-reviewed literature and is abundant across Southeast Asia, making it a more sustainable and cost-effective source than Galanthus snowdrop bulbs (which are limited to Eastern Europe). The final product meets USP Monograph specifications regardless of botanical origin.

Question 8

What shipping and packaging formats are available for export?

Accepted Answer

APIs are supplied in UN-certified HDPE drums (Y1.4/S rated) with double polyethylene liner bags and 5g silica gel desiccant sachets. Standard configurations: 25 kg drums (for commodity-volume orders), 10 kg drums, and 1–5 kg HDPE containers for sample orders. All shipments include export invoice, packing list, Certificate of Origin (Form A for EU GSP), phytosanitary certificate (IPPC), and GHS-compliant SDS. Cold-chain shipping (2–8°C) is available for Galantamine HBr. CITES documentation and DEA import/export permits are prepared where applicable.

Question 9

What is the shelf life and storage condition for your botanical APIs?

Accepted Answer

Assigned shelf lives: Galantamine HBr USP (36 months, store at 15–25°C in sealed container), Mitragynine 95% (24 months, store below 25°C protected from light), Nuciferine 98% (24 months, store at 15–25°C), Hyoscyamine Sulfate (36 months, store below 25°C). Stability studies conducted under ICH Q1A conditions (25°C/60%RH long-term; 40°C/75%RH accelerated). Reserve samples retained for one year past expiry date per ICH Q7 §11.7. Retest data available upon request.

Question 10

Can Phytrax supply Galantamine for an Alzheimer's drug product application?

Accepted Answer

Yes. Phytrax Galantamine HBr USP is produced under full PIC/S-compliant GMP with an active US FDA Drug Master File open for reference by qualified NDA/ANDA holders. The technical package includes: full impurity characterization (HPLC-MS), polymorphic form confirmation (XRPD), particle size distribution (D90 <100 μm by pin milling, with larger distributions available on request), elemental impurities per ICH Q3D, and genotoxic impurity assessment per ICH M7. Our regulatory team can support IND-enabling CMC documentation packages.

Question 11

What is the difference between ICH Q7 and EU GMP Annex 18 for API manufacturing?

Accepted Answer

EU GMP Annex 18 (now withdrawn and replaced by the Annex to Part II of the EU GMP Guide) was the European implementation of ICH Q7. Since the EU formally adopted ICH Q7 as Part II of the EU GMP Guide in 2005, Annex 18 was effectively superseded. For practical purposes, a facility that fully complies with ICH Q7 satisfies both the FDA's 21 CFR 211 expectations for API starting materials and the EU's Part II GMP requirements. Phytrax's facility is designed and operated to ICH Q7 as the primary standard.

Question 12

Does Phytrax offer custom botanical API extraction and isolation services?

Accepted Answer

Yes. Phytrax offers contract extraction and isolation services for alkaloid-bearing botanical raw materials available in Southeast Asia. Our shared process train (ethanol extraction, acid-base enrichment, preparative HPLC up to 30cm bore, recrystallization, vacuum drying) can be adapted for novel phytochemical targets. Feasibility studies start with a 100g raw material submission. Full GMP batch production requires a minimum 6-month technology transfer timeline. Confidentiality agreements (CDA/NDA) are executed before any feasibility work.

Precision botanical API,
manufactured to spec.

Commercial Scale & Industrial CDMO Capabilities

Preparative HPLC Chromatography

Live Commercial Portfolio

Mitragynine 95% Isolate

B2B Sourcing & Capacity Calculator

Regulatory Moat & Supply Chain Traceability

Validation Framework and Analytical Purity Standards

Scientific Foundation & Industry Intelligence

Why ICH Q7 Compliance Is the New Baseline for Botanical API Procurement

Galantamine HBr USP: The Alzheimer's API with a Sustainable Botanical Supply Problem

PIC/S Certification in ASEAN: What It Takes and Why It Changes the Supplier Conversation

Why Phytrax Works Only with Plant Extraction — Not Synthetic API Production

Small Molecules, Macromolecules, and Everything In Between: A Pharmacy Complexity Spectrum

The Botanical API Market in 2026: $10.5B and Growing at 9% CAGR — Who is Positioned to Capture It?

Frequently Asked Questions

Precision botanical API,manufactured to spec.